Best Practice & Research Clinical Endocrinology & Metabolism
Volume 20, Issue 1 , Pages 35-43 , March 2006

Assessment of in vivo assays for endocrine disruption

  • S.A. Clode, PhD (EU Registered Toxicologist)

      Affiliations

    • Corresponding Author InformationTel.: +44 1423 848116; fax: +44 1423 569594.

References 

  1. Endocrine Disruptor Screening and Testing Advisory Committee: final report. US environmental protection agency, office of prevention, pesticides and toxic substances, Washington, DC; 1998.
  2. Gray LE, Ostby J, Wilson V, et al. Xenoendocrine disrupters—tiered screening and testing. Filling key data gaps. Toxicology. 2002;181–183:371–382
  3. OECD series on testing and assessment no. 21 detailed review paper. Appraisal of test methods EENV/JM/MONO; 2002. p. 8.
  4. Zieger E. Current status of efforts to validate the EDSTAC tier 1 screening tests. CAAT Workshop. 2001;
  5. Jones RC, Edgren RA. The effects of various steroids on the vaginal histology in the rat. Fertility and Sterility. 1973;24:284–291
  6. OECD series on testing and assessment no. 38. Detailed background review of the uterotrophic bioassay ENV/JM/MONO; 2003. p. 1.
  7. Ogasawa Y, Okamoto S, Kitamura Y, Matsumoto K. Proliferative pattern of uterine cells from birth to adulthood in intact, neonatally castrated and/or adrenoectomized mice assayed by incorporation of [I125] iododeoxyuridine. Endocrinology. 1983;113:582–587
  8. Branham WS, Sheehan DM, Zehr DR, et al. The postnatal ontogeny of rat uterine glands and age-related effects of 17 beta-estradiol. Endocrinology. 1985;117:2229–2237
  9. Schlumpf M, Berger L, Cotton B, et al. Estrogen active uv screens. SFÖW-Journal. 2001;127:10–15
  10. Kanno J, Onyon L, Haseman J, et al. The OECD program to validate the rat uterotrophic assay to screen compounds for in vivo estrogenic responses: phase 1. Environmental Health Perspectives. 2001;109(8):785–794
  11. Santell RC, Chang YC, Nair MG, Helferich WG. Dietary genistein exerts estrogenic effects upon the uterus, mammary gland and the hypothalamic/pituitary axis in rats. Journal of Nutrition. 1997;127:263–269
  12. Owens W, Ashby J, Odum J, Onyon L. The OECD program to validate the rat uterotrophic bioassay. Phase 2: dietary phytoestrogen analysis. Environmental Health Perspectives. 2003;111(12):1559–1567
  13. Ashby J, Odum J, Foster JR. Activity of raloxifene in immature and OVX rat uterotrophic bioassays. Regulatory Toxicology and Pharmacology. 1997;25:226–231
  14. Ashby J, Lefevre PA, Odum J, et al. Failure to confirm estrogenic activity for benzoic acid and clofibrate: implications for list of endocrine-disrupting agents. Regulatory Toxicology and Pharmacology. 1997;26:96–101
  15. Tinwell H, Soames AR, Foster JR, Ashby J. Estradiol-type activity of coumestrol in mature and immature OVX rat uterotrophic bioassays. Environmental Health Perspectives. 2000;108:631–634
  16. Laws SC, Carey SA, Terrell JM, et al. Estrogenic activity of octylphenol, non-phenol, bisphenol A and methoxychlor in rats. Toxicological Sciences. 2000;54:154–167
  17. Kanno J, Onyon L, Peddada S, et al. The OECD Program to validate the rat uterotrophic bioassay. Phase 2: coded singe-dose studies. Environmental Health Perspectives. 2003;111(12):1550–1558
  18. Yamasaki K, Sawaki M, Noda S, et al. Immature uterotrophic assay of estrogenic compounds in rats given diets of different phytoestrogen content and the ovarian changes with ICI 182, 780 or antide. Archives of Toxicology 2002; 76:613–20.
  19. Gray LE, Kelce WR, Wiese T. Endocrine screening methods workshop report: detection of estrogenic and androgenic hormonal and anti-hormonal activity for chemicals that act via receptor or steroidogenic enzyme mechanisms. Reproductive Toxicology. 1997;11:719–750
  20. Yamasaki K, Sawaki M, Ohta R, et al. OECD validation of the Hershberger assay in Japan: phase 2 dose response of methyltestosterone, vinclozolin and p,p′-DDE. Environmental Health Perspectives. 2003;111(16):1912–1919
  21. Lambright C, Ostby J, Bobseine K, et al. Cellular and molecular mechanisms of action of linuron: an antiandrogenic herbicide that produces reproductive malformations in male rats. Toxicological Sciences. 2000;56:389–399
  22. O'Connor JC, Frane SR, Davis LG, Cook JC. Detection of the environmental antiandrogen p,p′-DDE in CD and long-evans rats using tier 1 screening battery and a Hershberger assay. Toxicological Sciences. 1999;51:44–53
  23. Laws SC, Ferrell JM, Stoker TE, et al. The effects of atrazine on female wistar rats: an evaluation of the protocol for assessing pubertal development and thyroid function. Toxicological Sciences. 2000;58(2):366–376
  24. Goldman JM, Laws SC, Balchak SK, et al. Endocrine-disrupting chemicals: prepubertal exposures and effects on sexual maturation and thyroid activity in the female rat. A focus on the EDSTAC recommendations. Critical Reviews in Toxicology. 2000;30(2):135–196
  25. Ashby J, Lefevre PA. The weanling male rat as an assay for endocrine disruption: preliminary observations. Regulatory Toxicology and Pharmacology. 1997;26:330–337
  26. Stoker TE, Parks LG, Gray LE, Cooper RL. Endocrine-disrupting chemicals: prepubertal exposures and effects on sexual maturation and thyroid function in the male rat. A focus on the EDSTAC recommendations. Critical Reviews in Toxicology. 2000;30:197–252
  27. Hofmann A. Presentation Given to CEFIC's Long Range Research Initiative (LRI) Workshop: 17–18 November, Brussels. 2004;
  28. Gray LE, Foster PMD. Significance of experimental studies for assessing adverse effects of endocrine-disrupting chemicals. Pure and Applied Chemistry. 2003;75(11–12):2125–2141

PII: S1521-690X(05)00078-3

doi: 10.1016/j.beem.2005.09.011

Best Practice & Research Clinical Endocrinology & Metabolism
Volume 20, Issue 1 , Pages 35-43 , March 2006

Article Tools

* Image Usage & Resolution